Metabolic activity by 18 F –FDG-PET/CT is predictive of early response after nivolumab in previously treated NSCLC

ConclusionMetabolic response by18F –FDG was effective in predicting efficacy and survival at 1 month after nivolumab treatment.
Source: European Journal of Nuclear Medicine and Molecular Imaging - Category: Nuclear Medicine Source Type: research